- The Daily Dividend
- Posts
- Here's What's New In The World Of Investing...
Here's What's New In The World Of Investing...
The Daily Dividend 12/15/25
Good morning!
It’s only Monday, and the good news is already flowing in. We’ve got a secret high-yielder announcing its latest special dividend, a Dividend King issuing another inflation-beating increase, and a hardware company hiking its quarterly distribution.
The special dividend takes center stage. So, let’s start with a blue chip stalwart’s massive one-time payout…
Old Republic International Corporation ($ORI) Declares $2.50 Special Dividend
Old Republic International Corporation is an insurance company that writes specialty and title policies. The company is a blue chip that’s been in business for over 100 years. And, Old Republic has paid uninterrupted dividends 84 years.
This is also a “secret high-yielder” stock thanks to the company’s frequent special dividend payments.
For example, last week Old Republic announced a $2.50 per share special distribution. Combine with the firm’s regular quarterly payments, this will give investors an 8.08% yield on cost.
Old Republic International Corporation will pay a one-time $2.50/share special distribution this January.
Ex-dividend date: 1/2/26
Payout date: 1/14/26
Forward starting dividend yield: 2.68%
Abbott Laboratories ($ABT) Raises Dividend By 6.8%
Over 100 years of nonstop quarterly dividend payments.
Abbott Laboratories has paid a dividend every quarter since 1924, and the company has raised its dividend for 54 consecutive years.
This is a healthcare company that makes both retail products like Similac and Pedialyte as well as high-tech medical devices such as pacemakers and glucose monitors. Abbott Laboratories has consistently raised its dividend at a rate that outpaces inflation, with payouts up 70% since 2020.
Last week, the company announced a 6.8% dividend increase.
Abbott Laboratories will now pay a $0.63/share quarterly dividend.
Ex-dividend date: 1/15/26
Payout date: 2/13/26
Forward starting dividend yield: 2.04%
Fortune Brands Innovations, Inc. ($FBIN) Raises Dividend By 4%
Here’s a hardware stock that rarely gets much attention despite owning several recognizable brands.
Fortune Brands Innovations, Inc. produces Moen sinks and faucets, Master Lock padlocks, Aqualisa shower fixtures, and Yale smart locks.
This company maintains a relatively low payout ratio as well as a five-year compound annual dividend growth rate of 4.04%. And last week, Fortune Brands announced its latest raise — a 4% dividend increase.
Fortune Brands Innovations, Inc. will now pay a $0.26/share quarterly dividend.
Ex-dividend date: 2/20/26
Payout date: 3/11/26
Forward starting dividend yield: 1.98%
Someone just spent $236,000,000 on a painting. Here’s why it matters for your wallet.
The WSJ just reported the highest price ever paid for modern art at auction.
While equities, gold, bitcoin hover near highs, the art market is showing signs of early recovery after one of the longest downturns since the 1990s.
Here’s where it gets interesting→
Each investing environment is unique, but after the dot com crash, contemporary and post-war art grew ~24% a year for a decade, and after 2008, it grew ~11% annually for 12 years.*
Overall, the segment has outpaced the S&P by 15 percent with near-zero correlation from 1995 to 2025.
Now, Masterworks lets you invest in shares of artworks featuring legends like Banksy, Basquiat, and Picasso. Since 2019, investors have deployed $1.25 billion across 500+ artworks.
Masterworks has sold 25 works with net annualized returns like 14.6%, 17.6%, and 17.8%.
Shares can sell quickly, but my subscribers skip the waitlist:
*Per Masterworks data. Investing involves risk. Past performance not indicative of future returns. Important Reg A disclosures: masterworks.com/cd
Thank you for reading and I hope your trading week is off to a great start!
P.S. Enjoying the newsletter? Forward it to a friend who loves dividends.
Disclaimer: This article is for entertainment purposes only. It is not financial advice, always do your own research.
